Ensign Peak Advisors, Inc Abcam PLC Transaction History

Ensign Peak Advisors, Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$15.5 - $23.89 $820,461 - $1.26 Million	-52,933 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$20.04 - $23.84 $3,146 - $3,742	-157 Reduced 0.3%	52,933 $1.25 Million
Q3 2021 Nov 12, 2021	BUY	$17.38 - $21.54 $173,904 - $215,529	10,006 Added 23.22%	53,090 $1.08 Million
Q1 2021 May 12, 2021	SELL	$19.22 - $24.3 $132,925 - $168,058	-6,916 Reduced 13.83%	43,084 $828,000
Q4 2020 Feb 12, 2021	BUY	$18.2 - $22.45 $910,000 - $1.12 Million	50,000 New	50,000 $1.08 Million

1.03M

Ticker ABCM
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 229,044,992
Description
Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include...

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ensign Peak Advisors, Inc with notifications on news.